caffeic acid phenethyl ester has been researched along with Androgen-Independent Prostatic Cancer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jeong, CW; Kang, M; Kim, HH; Ku, JH; Kwak, C; Lee, HS; Lee, KH | 1 |
Chan, TM; Chang, CH; Chen, LT; Chuu, CP; Hsiao, PH; Huo, C; Jiang, SS; Kung, HJ; Lin, CY; Lin, HP; Su, LC; Wang, HD | 1 |
Chen, Y; Hu, X; Li, C; Li, Q; Zhang, H; Zhang, L; Zhao, Y; Zheng, X | 1 |
3 other study(ies) available for caffeic acid phenethyl ester and Androgen-Independent Prostatic Cancer
Article | Year |
---|---|
Concurrent treatment with simvastatin and NF-κB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anti-cancer effects via control of the NF-κB/LIN28/let-7 miRNA signaling pathway.
Topics: Antineoplastic Combined Chemotherapy Protocols; Caffeic Acids; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Male; MicroRNAs; NF-kappa B; Phenylethyl Alcohol; Prostatic Neoplasms, Castration-Resistant; RNA-Binding Proteins; Signal Transduction; Simvastatin | 2017 |
Caffeic acid phenethyl ester induced cell cycle arrest and growth inhibition in androgen-independent prostate cancer cells via regulation of Skp2, p53, p21Cip1 and p27Kip1.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Caffeic Acids; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Drug Synergism; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Phenylethyl Alcohol; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Prostatic Neoplasms, Castration-Resistant; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; RNA Interference; S-Phase Kinase-Associated Proteins; Signal Transduction; Time Factors; Transfection; Tumor Burden; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |
In vitro CAPE inhibitory activity towards human AKR1C3 and the molecular basis.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Binding Sites; Caffeic Acids; Crystallography, X-Ray; Humans; Hydroxybenzoates; Hydroxyprostaglandin Dehydrogenases; Male; Phenylethyl Alcohol; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Protein Structure, Tertiary | 2016 |